COVID-19 vaccine safety surveillance Our work Main navigation National vaccine safety surveillance Active vaccine safety surveillance COVID-19 vaccine safety surveillance What is AusVaxSafety doing? How will AusVaxSafety monitor vaccine safety? Information for immunisation providers COVID-19 vaccine safety surveillance FAQ COVID-19 vaccine safety data Adverse event of special interest (AESI) long-term follow-up program Adverse Events Following Immunisation Clinical Assessment Network (AEFI-CAN) Vaccine safety in Australia AusVaxSafety summary report Publications AusVaxSafety is conducting national COVID-19 vaccine safety surveillance in Australia. This is to ensure ongoing safety of COVID-19 vaccines used in Australia to promote provider and public confidence in the vaccination program. Click on the tiles below to find out more. What is AusVaxSafety doing? AusVaxSafety is conducting active safety surveillance of COVID-19 vaccines in Australia. Find out more here. How does AusVaxSafety monitor vaccine safety? Find out how is AusVaxSafety monitoring COVID-19 vaccine safety here. Information for immunisation providers GPs/immunisation providers can get involved in monitoring COVID-19 vaccine safety. Find out more here. COVID-19 vaccine safety surveillance FAQ Answers to some of the frequently asked questions about COVID-19 vaccine safety surveillance in Australia. COVID-19 vaccine safety data COVID-19 vaccine safety results are available publicly. Find out more here. Our work Main navigation National vaccine safety surveillance Active vaccine safety surveillance COVID-19 vaccine safety surveillance What is AusVaxSafety doing? How will AusVaxSafety monitor vaccine safety? Information for immunisation providers COVID-19 vaccine safety surveillance FAQ COVID-19 vaccine safety data Adverse event of special interest (AESI) long-term follow-up program Adverse Events Following Immunisation Clinical Assessment Network (AEFI-CAN) Vaccine safety in Australia AusVaxSafety summary report Publications News & events All news & events 28 November 2023 | News AusVaxSafety monitoring monovalent Omicron XBB.1.5 variant COVID-19 vaccine safety 07 November 2023 | News AusVaxSafety commences enhanced surveillance of Shingrix® following addition to the NIP schedule 19 October 2023 | News AusVaxSafety surveillance of 2023 seasonal flu vaccines concludes with no safety issues identified 14 September 2023 | News Vaxtracker wins Hunter New England Health Excellence Award